Hughes syndrome and Multiple sclerosis

dc.contributor.authorUthman, Imad W.
dc.contributor.authorNoureldine, Mohammad Hassan A.
dc.contributor.authorBerjawi, Ahmad
dc.contributor.authorSkaf, M.
dc.contributor.authorHaydar, Ali A.
dc.contributor.authorMerashli, Mira
dc.contributor.authorHughes, Graham R.V.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentDivision of Allergy, Immunology and Rheumatology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:47:34Z
dc.date.available2025-01-24T11:47:34Z
dc.date.issued2015
dc.description.abstractMultiple sclerosis (MS) and antiphospholipid syndrome (APS) share common clinical, laboratory and radiological features. We reviewed all the English papers on MS and APS published in the literature from 1965 to 2014 using PubMed and Google Scholar. We found that APS can mimic antiphospholipid antibodies (aPL)-positive MS in many ways in its clinical presentation. Nevertheless, APS diagnosis, clinical manifestations and management differ from those of MS. aPL were found in MS patients with titers ranging from 2% to 88%. The distribution and volume of lesions on magnetic resonance imaging (MRI) may help to differentiate MS from primary APS. In addition, atypical MS presentation can guide physicians toward an alternative diagnosis, especially when features of thrombosis and/or history of connective tissue disease are present. In that case, an anticoagulation trial could be worthwhile. © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
dc.identifier.doihttps://doi.org/10.1177/0961203314555539
dc.identifier.eid2-s2.0-84921473949
dc.identifier.pmid25326228
dc.identifier.urihttp://hdl.handle.net/10938/30750
dc.language.isoen
dc.publisherSAGE Publications Ltd
dc.relation.ispartofLupus
dc.sourceScopus
dc.subjectAntiphospholipid antibodies (apl)
dc.subjectAntiphospholipid syndrome (aps)
dc.subjectHughes syndrome
dc.subjectMultiple sclerosis (ms)
dc.subjectAntibodies, antiphospholipid
dc.subjectAnticoagulants
dc.subjectAntiphospholipid syndrome
dc.subjectDiagnosis, differential
dc.subjectHumans
dc.subjectMagnetic resonance imaging
dc.subjectMultiple sclerosis
dc.subjectThrombosis
dc.subjectAcetylsalicylic acid
dc.subjectBeta1 interferon
dc.subjectCorticosteroid
dc.subjectImmunoglobulin
dc.subjectPhospholipid antibody
dc.subjectAnticoagulant agent
dc.subjectAntibody titer
dc.subjectAnticoagulant therapy
dc.subjectClinical feature
dc.subjectCorticosteroid therapy
dc.subjectHuman
dc.subjectNuclear magnetic resonance imaging
dc.subjectPatient care
dc.subjectPriority journal
dc.subjectReview
dc.subjectDifferential diagnosis
dc.subjectImmunology
dc.subjectPathophysiology
dc.titleHughes syndrome and Multiple sclerosis
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2015-10280.pdf
Size:
92.66 KB
Format:
Adobe Portable Document Format